Overdose prevention support after emergency department care
Treatments studied
Part of Mental health clinical trials.
This study tests a package of support services to help people who have had an opioid overdose and are starting buprenorphine in the emergency department. The goal is to keep them safe and reduce the chance of another overdose.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older
- You must have had an opioid overdose in the past 12 months
- You must have been prescribed buprenorphine (medication that reduces opioid cravings) in the emergency department and be willing to keep taking it after leaving
- You must be able to speak English
- You must be discharged from the emergency department or hospital at UAB (in Alabama)
- You must live in Alabama and not be in jail, prison, or pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a bundled approach to help adults who have had an opioid overdose and are starting buprenorphine in the emergency department continue their recovery after being discharged. It is for people who want to stay on buprenorphine and need support after leaving the hospital.
This Phase 4 study tests an “emergency opioid engagement system” that aims to help people who are opioid-dependent start stopping opioid use. If you’re willing to stop and can safely participate, the program may offer structured support when you’re in the emergency setting.
This study offers an engagement program for young people who tested positive for opioids and meet criteria for opioid dependence. The goal is to help participants stop opioid use safely and learn whether this approach works well in the real-world emergency setting.
This study tests extra support to help people who recently started buprenorphine treatment for opioid use disorder stay on track with their recovery, especially if they are new to treatment or recently released from jail or prison.
This study compares a higher dose of buprenorphine (a medicine that helps stop opioid cravings and withdrawal) to the usual dose, given in the emergency department. It aims to see if the higher dose works better to start treatment for opioid use disorder.
This Phase 3 study tests whether starting a high dose of buprenorphine in the emergency department helps people with opioid use disorder come through withdrawal more safely and effectively. It focuses on people whose urine test shows fentanyl and who are already in withdrawal when they arrive.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.